Under IFRS, internally generated development costs are capitalized when technical feasibility, intent and ability to complete and use or sell, probable future benefits, and reliable cost measurement criteria are met. Research costs are expensed. US GAAP is generally stricter and expenses most internal R&D. Capitalizing too early or treating research like development is a frequent classification trap.